To test this notion, we administered a targeted immunotoxin to 5 Mamu-A*01+ rhesus macaques with established SIVmac239 infection, aiming to deplete CM9-specific CD8+ T cells, and measured the impact of this intervention among tissues and PBMCs (Figure 1A). This evidence concerns the gene CD8A and infection.